Physician
Serra Community Medical Clinic INC
Serra Community Medical Clinic INC was paid $12.81M by Medicaid between Jan 2018 and Nov 2024, across 242 billing codes. Its largest line is G9012, Other specified case management service not elsewhere classified — 65% of everything it billed.
33Billing provider infoSERRA COMMUNITY MEDICAL CLINIC INC
SUN VALLEY, CA 91352
SUN VALLEY, CA 91352
33aNPI1275545725assigned 08/13/2006
33bProvider typeAllergy Physician
28Total paid$12.81M
24GClaims1,060,825
24DCodes billed242
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Allergy Physician providers in California
Rank by total paid#1 of 56
Median peer was paid$150K
This provider vs. median85×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 100,096 | $420K | |
| 2019 | 133,116 | $543K | |
| 2020 | 93,143 | $447K | |
| 2021 | 133,134 | $689K | |
| 2022 | 181,945 | $2.57M | |
| 2023 | 231,555 | $4.37M | |
| 2024incomplete | 187,836 | $3.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G9012 | Other specified case management service not elsewhere classified | 65% | 41,538 | 26,834 | $8.36M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 77,663 | 68,009 | $1.25M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.7% | 47,451 | 42,553 | $596K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.2% | 14,828 | 12,969 | $406K |
| 97802 | 1.1% | 19,535 | 19,068 | $147K | |
| 99490 | Ccm add 20min | <1% | 7,538 | 7,450 | $108K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,206 | 3,198 | $108K |
| 99487 | Ccm add 20min | <1% | 3,383 | 3,370 | $106K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,184 | 4,176 | $85K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,440 | 2,425 | $82K |
| G9920 | Screening performed and negative | <1% | 8,200 | 8,168 | $82K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,793 | 7,752 | $53K |
230 more codes
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 734 | $49K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,377 | $47K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,264 | $46K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,565 | $44K |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 302 | $43K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,348 | $42K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,836 | $41K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,519 | $38K |
| 92551 | <1% | 9,879 | $35K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,419 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,312 | $32K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,649 | $31K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12,547 | $30K |
| 99489 | Ccm add 20min | <1% | 1,008 | $28K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 668 | $26K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,946 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,980 | $25K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,959 | $25K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,099 | $25K |
| 82607 | <1% | 5,805 | $24K | |
| 90686 | <1% | 6,344 | $24K | |
| 76642 | <1% | 1,044 | $23K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,194 | $22K |
| 82746 | <1% | 5,308 | $22K | |
| 80061 | Lipid panel | <1% | 8,457 | $22K |
| 92015 | Determination of refractive state | <1% | 4,088 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,532 | $22K |
| 93000 | <1% | 4,484 | $21K | |
| 80053 | Comprehensive metabolic panel | <1% | 9,024 | $18K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 686 | $16K |
| 82043 | <1% | 10,576 | $16K | |
| 82565 | <1% | 13,387 | $15K | |
| V2020 | Frames, purchases | <1% | 801 | $15K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 310 | $14K |
| 80074 | <1% | 1,805 | $14K | |
| 99383 | <1% | 1,310 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,091 | $13K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,646 | $13K |
| 82570 | <1% | 10,603 | $13K | |
| 82947 | <1% | 14,918 | $13K | |
| 82247 | <1% | 13,846 | $12K | |
| 76830 | Ultrasound, transvaginal | <1% | 451 | $12K |
| 99491 | Ccm add 20min | <1% | 547 | $11K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 321 | $10K |
| 84520 | <1% | 13,348 | $10K | |
| 85018 | <1% | 26,750 | $10K | |
| 86803 | <1% | 2,546 | $9K | |
| 86696 | <1% | 1,944 | $9K | |
| 81002 | <1% | 13,670 | $9K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,825 | $9K |
| 99384 | <1% | 820 | $9K | |
| 90651 | <1% | 2,239 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 176 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 264 | $8K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 214 | $8K |
| 77080 | <1% | 566 | $8K | |
| 82728 | <1% | 2,243 | $8K | |
| 93970 | <1% | 192 | $7K | |
| 59425 | <1% | 876 | $7K | |
| 84436 | <1% | 4,791 | $7K | |
| 84132 | <1% | 13,372 | $7K | |
| 87340 | <1% | 2,645 | $7K | |
| 84479 | <1% | 4,590 | $7K | |
| 84155 | <1% | 13,802 | $6K | |
| 86695 | <1% | 1,942 | $6K | |
| 90734 | <1% | 2,037 | $6K | |
| 90620 | <1% | 1,920 | $6K | |
| 99285 | Emergency room visit (most serious) | <1% | 195 | $6K |
| 86694 | <1% | 1,853 | $6K | |
| 84439 | <1% | 2,394 | $5K | |
| 84100 | <1% | 5,242 | $5K | |
| 84481 | <1% | 1,166 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 199 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,039 | $5K |
| 85049 | <1% | 13,625 | $4K | |
| 97010 | <1% | 3,386 | $4K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,889 | $4K |
| 86780 | <1% | 1,055 | $4K | |
| 92002 | <1% | 110 | $4K | |
| 85048 | <1% | 13,749 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 603 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 886 | $3K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 8,508 | $3K |
| 81001 | <1% | 5,297 | $3K | |
| 99283 | Emergency room visit (moderate) | <1% | 308 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,199 | $3K |
| 90670 | <1% | 515 | $3K | |
| 86592 | <1% | 2,607 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 738 | $3K |
| 90698 | <1% | 407 | $2K | |
| 82310 | <1% | 13,347 | $2K | |
| 83550 | <1% | 1,351 | $2K | |
| 83540 | <1% | 1,440 | $2K | |
| 84450 | <1% | 13,759 | $2K | |
| 90682 | <1% | 133 | $2K | |
| 82948 | <1% | 2,976 | $2K | |
| 84075 | <1% | 13,778 | $2K | |
| 90716 | <1% | 345 | $2K | |
| 82270 | <1% | 1,742 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,233 | $2K |
| 90707 | <1% | 276 | $1K | |
| 82465 | <1% | 12,434 | $1K | |
| 90715 | <1% | 422 | $1K | |
| 76770 | <1% | 56 | $1K | |
| 76801 | <1% | 46 | $1K | |
| 1036F | <1% | 65,222 | $1K | |
| 11721 | <1% | 219 | $1K | |
| 87088 | <1% | 692 | $1K | |
| 99406 | <1% | 549 | $1K | |
| 84295 | <1% | 13,349 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 195 | $1K |
| 73562 | <1% | 134 | $1K | |
| 82435 | <1% | 13,331 | $1K | |
| 99221 | <1% | 90 | $1K | |
| 72192 | <1% | 27 | $1K | |
| 90633 | <1% | 176 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 34 | $949.12 |
| 93307 | <1% | 15 | $933.74 | |
| 99253 | <1% | 32 | $880.56 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 142 | $839.73 |
| 90685 | <1% | 149 | $807.47 | |
| 84153 | <1% | 128 | $793.31 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 58 | $748.66 |
| 84445 | <1% | 61 | $716.03 | |
| 84480 | <1% | 186 | $685.35 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 109 | $673.35 |
| 73630 | <1% | 54 | $671.44 | |
| 81025 | <1% | 499 | $649.19 | |
| 97161 | <1% | 848 | $626.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 886 | $624.00 |
| 84460 | <1% | 13,747 | $612.29 | |
| 99284 | Emergency room visit (serious) | <1% | 95 | $609.03 |
| 85014 | <1% | 13,607 | $607.76 | |
| 86580 | <1% | 618 | $589.41 | |
| 90744 | <1% | 95 | $585.62 | |
| 84478 | <1% | 12,423 | $580.33 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 459 | $578.37 |
| 90677 | <1% | 57 | $569.19 | |
| 72110 | <1% | 49 | $564.33 | |
| 82248 | <1% | 657 | $554.64 | |
| 82374 | <1% | 13,342 | $509.99 | |
| 83718 | <1% | 12,433 | $469.51 | |
| 00812 | <1% | 12 | $443.84 | |
| 90662 | <1% | 96 | $441.96 | |
| 99223 | Prolong inpt eval add15 m | <1% | 13 | $441.87 |
| 80076 | <1% | 258 | $432.52 | |
| 86705 | <1% | 2,478 | $413.41 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 507 | $386.77 |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,169 | $385.10 |
| 82040 | <1% | 13,759 | $346.90 | |
| 86709 | <1% | 2,480 | $328.88 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 430 | $304.95 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 38 | $294.88 |
| 86376 | <1% | 133 | $294.61 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 600 | $287.03 |
| 90696 | <1% | 56 | $279.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,430 | $273.22 |
| 99000 | <1% | 102 | $240.53 | |
| 90658 | <1% | 301 | $234.00 | |
| 87184 | <1% | 169 | $196.93 | |
| 84550 | <1% | 261 | $196.90 | |
| 99173 | <1% | 9,301 | $184.68 | |
| 99201 | <1% | 40 | $181.36 | |
| 76536 | <1% | 13 | $177.42 | |
| 71045 | Radiologic examination, chest; single view | <1% | 41 | $171.48 |
| 85060 | <1% | 104 | $162.70 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 12 | $161.18 |
| 88141 | <1% | 61 | $156.32 | |
| 90681 | <1% | 25 | $135.00 | |
| 97014 | <1% | 37 | $121.33 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 39 | $104.97 |
| 86140 | <1% | 121 | $82.08 | |
| 73030 | <1% | 12 | $76.80 | |
| 85651 | <1% | 151 | $68.98 | |
| 83655 | <1% | 26 | $67.90 | |
| 97032 | <1% | 488 | $60.00 | |
| 85730 | <1% | 41 | $53.10 | |
| 73610 | <1% | 15 | $49.78 | |
| 90697 | <1% | 12 | $45.00 | |
| 3288F | <1% | 210 | $38.38 | |
| 85044 | <1% | 91 | $36.68 | |
| 3044F | <1% | 9,867 | $36.23 | |
| 85610 | <1% | 41 | $34.60 | |
| 82962 | <1% | 1,778 | $25.20 | |
| 3061F | <1% | 7,629 | $19.31 | |
| 97035 | <1% | 174 | $14.72 | |
| 83690 | <1% | 104 | $11.66 | |
| 86901 | <1% | 27 | $9.79 | |
| 86900 | <1% | 27 | $9.47 | |
| 3060F | <1% | 1,189 | $6.42 | |
| 87070 | <1% | 32 | $0.14 | |
| 3072F | <1% | 623 | $0.12 | |
| 2022F | <1% | 399 | $0.11 | |
| 84702 | <1% | 30 | $0.09 | |
| 3074F | <1% | 39,080 | $0.07 | |
| 3078F | <1% | 40,307 | $0.05 | |
| 3077F | <1% | 9,642 | $0.04 | |
| 86800 | <1% | 18 | $0.02 | |
| 2023F | <1% | 302 | $0.02 | |
| 0502F | <1% | 2,250 | $0.01 | |
| 1003F | <1% | 11,932 | $0.01 | |
| 3079F | <1% | 11,346 | $0.01 | |
| 3075F | <1% | 6,101 | $0.01 | |
| 1158F | 0% | 184 | $0.00 | |
| 1160F | 0% | 1,530 | $0.00 | |
| 3046F | 0% | 54 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 89 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 329 | $0.00 |
| 1090F | 0% | 173 | $0.00 | |
| 3045F | 0% | 176 | $0.00 | |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 0% | 99 | $0.00 |
| 1159F | 0% | 370 | $0.00 | |
| T4541 | Incontinence product, disposable underpad, large, each | 0% | 38 | $0.00 |
| 4040F | 0% | 53 | $0.00 | |
| 3050F | 0% | 36 | $0.00 | |
| 91312 | 0% | 12 | $0.00 | |
| 0124A | 0% | 12 | $0.00 | |
| 3080F | 0% | 3,652 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 18,059 | $0.00 |
| 1170F | 0% | 229 | $0.00 | |
| 1101F | 0% | 128 | $0.00 | |
| 3048F | 0% | 44 | $0.00 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 0% | 529 | $0.00 |
| 99496 | 0% | 30 | $0.00 | |
| 1126F | 0% | 109 | $0.00 | |
| 1111F | 0% | 78 | $0.00 | |
| 1015F | 0% | 138 | $0.00 | |
| 87077 | 0% | 25 | $0.00 | |
| 99495 | 0% | 12 | $0.00 | |
| 0500F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPEREZ, LILY (CREDENTIALING COORDINATOR)